Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials

This study has been withdrawn prior to enrollment.
(Too difficult to select patient according to the investigator)
Sponsor:
Collaborator:
Axial Biotech, Inc
Information provided by (Responsible Party):
Laboratoires Thea
ClinicalTrials.gov Identifier:
NCT01546012
First received: March 2, 2012
Last updated: August 31, 2015
Last verified: August 2015

March 2, 2012
August 31, 2015
Not Provided
Not Provided
Overall preference of the patient [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
At Visit2: Week 6 +/- 1week: End of Study Visit. "Overall preference of the patient": number of answers Hyabak, Hylo-comod.
Same as current
Complete list of historical versions of study NCT01546012 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials
Not Provided
Assess the patient feeling about the handiness of two different vials used to deliver both, unpreserved hyaluronic eye drops.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Assess the Patient Feeling About the Handiness of Two Different Vials Used to Deliver Both, Unpreserved Hyaluronic Eye Drops
  • Device: HYABAK®
    Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)
  • Device: HYLO-COMOD®
    Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)
  • Experimental: HYABAK®
    Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)
    Intervention: Device: HYABAK®
  • Active Comparator: HYLO-COMOD®:
    Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)
    Intervention: Device: HYLO-COMOD®
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
Not Provided
Not Provided

Inclusion Criteria:

  • Man or woman aged 18 and older
  • Patient with dry eye for at least 3 months
  • Having given his written informed consent

Exclusion Criteria:

  • Intolerance to studied products
  • Patient's inability to understand the study procedures and give informed consent.
  • Patient unwilling to follow the study procedures and visits defined by the protocol.
  • Pregnant or lactating women.
  • Patient under guardian ship
Both
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01546012
LT1550-PIV-CE-10/11, 2012-001233-14
No
Not Provided
Not Provided
Laboratoires Thea
Laboratoires Thea
Axial Biotech, Inc
Principal Investigator: Carl Erb Augenklinik, Wittenbergplatz, Kleiststrasse 23-26, 10787 Berlin
Laboratoires Thea
August 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP